After treatment with the MIF inhibitor ISO-1, the tissue pathological damage and inflammatory infiltration were reduced in the SAP-AKI model, along with decreased MIF mRNA level and NLRP3 expression level (Liu et al., 2021). The gene discussed is NLRP3; the disease is acute kidney injury.